Home
ALNY
ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on September 16, 2025

Will Positive HELIOS-B Data and $575 Million Offering Transform Alnylam’s (ALNY) RNAi Therapy Narrative?

Simply Wall St.

3 days ago

Will Positive HELIOS-B Data and $575 Million Offering Transform Alnylam’s (ALNY) RNAi Therapy Narrative?

Top 20 biopharma market caps fall 5.7% amid industry challenges

Pharmaceutical Technology

6 days ago

Top 20 biopharma market caps fall 5.7% amid industry challenges

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

Zacks

6 days ago

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

MT Newswires

6 days ago

Alnylam Pharmaceuticals Prices Upsized $575 Million Convertible Senior Notes Offering

Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes

Business Wire

7 days ago

Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes

MT Newswires

8 days ago

Alnylam Launches $500 Million Convertible Notes Offering

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

Business Wire

8 days ago

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Zacks

8 days ago

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

Zacks

12 days ago

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

RNAi Technology Market Size to Reach USD 6.63 Billion with 10.4% CAGR by 2033, Report by DataM Intelligence

PR Newswire

12 days ago

RNAi Technology Market Size to Reach USD 6.63 Billion with 10.4% CAGR by 2033, Report by DataM Intelligence

MT Newswires

14 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?

Insider Monkey

14 days ago

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

PR Newswire

14 days ago

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

Alnylam reports new analysis from trial of Amvuttra for ATTR-CM

Clinical Trials Arena

14 days ago

Alnylam reports new analysis from trial of Amvuttra for ATTR-CM

Startup Corsera Health aims to bring preventive heart medicine to the masses

BioPharma Dive

14 days ago

Startup Corsera Health aims to bring preventive heart medicine to the masses

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Zacks

15 days ago

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Analysts Are Optimistic We'll See A Profit From Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Simply Wall St.

16 days ago

Analysts Are Optimistic We'll See A Profit From Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Large-cap biotech is a sector to watch for investors: Analysts

Yahoo Finance

16 days ago

Large-cap biotech is a sector to watch for investors: Analysts

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

Business Wire

16 days ago

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

Business Wire

17 days ago

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

Business Wire

17 days ago

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

GlobeNewswire

17 days ago

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Zacks

19 days ago

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals

GlobeNewswire

19 days ago

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

19 days ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Business Wire

20 days ago

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Simply Wall St.

21 days ago

Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Scenic Enters License and Research Agreement with Alnylam

GlobeNewswire

21 days ago

Scenic Enters License and Research Agreement with Alnylam

Leaders Come Together to Advance the Industry at Veeva Summit

PR Newswire

a month ago

Leaders Come Together to Advance the Industry at Veeva Summit

MT Newswires

a month ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing

MT Newswires

a month ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing

MT Newswires

a month ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing

MT Newswires

a month ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,299,746, According to a Recent SEC Filing

Three Companies That Might Be Priced Below Their Estimated Value

Simply Wall St.

a month ago

Three Companies That Might Be Priced Below Their Estimated Value

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt?

Simply Wall St.

a month ago

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt?

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now.

Barrons.com

a month ago

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now.

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

Barchart

a month ago

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

a month ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Simply Wall St.

a month ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

Business Wire

a month ago

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The US Market

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In The US Market

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?

Simply Wall St.

3 months ago

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?

Exploring Three High Growth Tech Stocks in the US Market

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks in the US Market

Exploring US High Growth Tech Stocks For Potential Opportunities

Simply Wall St.

3 months ago

Exploring US High Growth Tech Stocks For Potential Opportunities

US High Growth Tech Stocks To Watch In June 2025

Simply Wall St.

3 months ago

US High Growth Tech Stocks To Watch In June 2025

High Growth Tech Stocks To Watch In US June 2025

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In US June 2025

Exploring US High Growth Tech Stocks To Watch In June 2025

Simply Wall St.

3 months ago

Exploring US High Growth Tech Stocks To Watch In June 2025

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks In The US Market

High Growth Tech Stocks in US for June 2025

Simply Wall St.

3 months ago

High Growth Tech Stocks in US for June 2025

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The US Market

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

Simply Wall St.

3 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

Alnylam names Pushkal Garg as EVP, chief research and development officer

TipRanks

3 months ago

Alnylam names Pushkal Garg as EVP, chief research and development officer

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Business Wire

3 months ago

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Exploring High Growth Tech Opportunities in US Markets

Simply Wall St.

3 months ago

Exploring High Growth Tech Opportunities in US Markets

Exploring High Growth Tech Stocks In The US This June 2025

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In The US This June 2025

The European Commission Approves Alnylam’s AMVUTTRA

Insider Monkey

3 months ago

The European Commission Approves Alnylam’s AMVUTTRA

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

GlobeNewswire

3 months ago

Instil Bio Names John Maraganore, Ph.D., to Board Role Supporting the Advancement of PD-L1xVEGF Bispecific Antibody Program

Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM

Zacks

3 months ago

Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM

EC approves Alnylam’s vutrisiran for ATTR-CM treatment

Pharmaceutical Technology

3 months ago

EC approves Alnylam’s vutrisiran for ATTR-CM treatment

MT Newswires

3 months ago

Alnylam Gets EU Approval for RNAi Drug to Treat Transthyretin Amyloidosis With Cardiomyopathy

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Business Wire

3 months ago

Alnylam Receives European Commission Approval for AMVUTTRA® (vutrisiran) for the Treatment of ATTR Amyloidosis with Cardiomyopathy

Why Is Sarepta Therapeutics (SRPT) Up 7.7% Since Last Earnings Report?

Zacks

3 months ago

Why Is Sarepta Therapeutics (SRPT) Up 7.7% Since Last Earnings Report?

This week in Trumponomics: Too bad TACO isn’t true

Yahoo Finance

4 months ago

This week in Trumponomics: Too bad TACO isn’t true

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Yahoo Finance Video

4 months ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Reuters

4 months ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states

USA TODAY

4 months ago

Smoke from Canadian wildfires worsens air quality in Dakotas, Midwestern states

Saturday Sessions: OK Go performs "Love"

CBS News Videos

4 months ago

Saturday Sessions: OK Go performs "Love"

Behind the scenes of an OK Go music video

CBS News Videos

4 months ago

Behind the scenes of an OK Go music video

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital

Simply Wall St.

4 months ago

Some Investors May Be Worried About Marine Products' (NYSE:MPX) Returns On Capital

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back

Investor's Business Daily

4 months ago

Dow Jones Futures: Stocks At Key Levels Amid Trump Tariff News; Palantir Breaks Out As Tesla, Nvidia Fall Back

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference

Business Wire

4 months ago

Alnylam to Webcast Presentation at Goldman Sachs 46th Annual Global Healthcare Conference

3 High-Flying Stocks That Could Soar Even More

Motley Fool

4 months ago

3 High-Flying Stocks That Could Soar Even More

Alnylam Issues 2024 Corporate Responsibility Report

Business Wire

4 months ago

Alnylam Issues 2024 Corporate Responsibility Report

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

MT Newswires

4 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $3,124,217, According to a Recent SEC Filing

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

Business Wire

4 months ago

AMVUTTRA® (vutrisiran) Significantly Reduces Mortality and a Range of Important Cardiovascular Events in Patients with ATTR Amyloidosis with Cardiomyopathy: Additional Data from HELIOS-B

High Growth US Tech Stocks To Watch In May 2025

Simply Wall St.

4 months ago

High Growth US Tech Stocks To Watch In May 2025

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term

Insider Monkey

4 months ago

Alnylam Pharmaceuticals, Inc. (ALNY): Among the Best Growth Stocks to Buy and Hold for the Long Term

Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) To Present Pivotal TTR Franchise Data At Heart Failure Congress

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) Path To Profitability

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Vir Biotechnology Inc Earnings Call

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Simply Wall St.

4 months ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications

Pharma Voice

4 months ago

Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

GuruFocus.com

4 months ago

Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference

Business Wire

4 months ago

Alnylam to Webcast Presentation at BofA Securities 2025 Health Care Conference

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report

Simply Wall St.

4 months ago

Analyst Estimates: Here's What Brokers Think Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) After Its First-Quarter Report

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

Zacks

4 months ago

Alnylam Q1 Earnings Beat Estimates, Product Revenues Rise Y/Y

MT Newswires

4 months ago

UBS Adjusts Alnylam Pharmaceuticals Price Target to $349 From $331, Maintains Buy Rating

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...

GuruFocus.com

4 months ago

Alnylam Pharmaceuticals Inc (ALNY) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ...

Thomson Reuters StreetEvents

4 months ago

Q1 2025 Alnylam Pharmaceuticals Inc Earnings Call

Morningstar Research

4 months ago

Analyst Report: Alnylam Pharmaceuticals, Inc.

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics

Zacks

5 months ago

Compared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics

Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates

Zacks

5 months ago

Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates

MT Newswires

5 months ago

Alnylam Q1 Non-GAAP Net Loss Narrows, Revenue Rises

Associated Press Finance

5 months ago

Alnylam: Q1 Earnings Snapshot

Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress

Business Wire

5 months ago

Alnylam Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Period Progress

Share on Social Networks: